検索
Zai Lab Ltd
ZLABウォッチリストに追加
20.590USD
+0.260+1.28%
終値 05/15, 16:00（ET）15分遅れの株価
2.33B時価総額
損失額直近12ヶ月PER
詳細情報 Zai Lab Ltd 企業名
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Zai Lab Ltdの企業情報
企業コードZLAB
会社名Zai Lab Ltd
上場日Sep 28, 2020
最高経営責任者「CEO」Du (Ying)
従業員数1869
証券種類Depository Receipt
決算期末Sep 28
本社所在地Building B, 899 Halei Road, Pudong
都市SHANGHAI
証券取引所NASDAQ OMX - NASDAQ BASIC
国China
郵便番号201203
電話番号862161632588
ウェブサイトhttps://www.zailaboratory.com/
企業コードZLAB
上場日Sep 28, 2020
最高経営責任者「CEO」Du (Ying)
Zai Lab Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
117.60K
+22.60%
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+10.86%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-8.50%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
19.15K
-4.46%
Dr. Ying (Samantha) Du, Ph.D.
Dr. Ying (Samantha) Du, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--
Mr. Peter Karl Wirth, J.D.
Mr. Peter Karl Wirth, J.D.
Independent Director
Independent Director
--
--
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Frazor Titus Edmondson, J.D.
Mr. Frazor Titus Edmondson, J.D.
Company Secretary, Chief Legal Officer
Company Secretary, Chief Legal Officer
--
--
Mr. Scott W. Morrison, CPA
Mr. Scott W. Morrison, CPA
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
117.60K
+22.60%
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+10.86%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-8.50%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
19.15K
-4.46%
Dr. Ying (Samantha) Du, Ph.D.
Dr. Ying (Samantha) Du, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Mon, Apr 6
通貨: USD更新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
事業別USD
会社名
収益
比率
ZEJULA
189.04M
41.35%
VYVGART
94.20M
20.60%
NUZYRA
60.84M
13.31%
Optune
48.33M
10.57%
QINLOCK
35.61M
7.79%
他の
29.17M
6.38%
地域別USD
会社名
収益
比率
China (Mainland)
460.16M
0.00%
事業別
地域別
事業別USD
会社名
収益
比率
ZEJULA
189.04M
41.35%
VYVGART
94.20M
20.60%
NUZYRA
60.84M
13.31%
Optune
48.33M
10.57%
QINLOCK
35.61M
7.79%
他の
29.17M
6.38%
株主
更新時刻: Thu, May 14
更新時刻: Thu, May 14
株主統計
種類
株主統計
株主統計
比率
RTW Investments L.P.
6.19%
RA Capital Management, LP
5.11%
Norges Bank Investment Management (NBIM)
3.42%
Frazier Life Sciences Management, L.P.
1.69%
ClearBridge Investments, LLC
1.61%
他の
81.97%
株主統計
株主統計
比率
RTW Investments L.P.
6.19%
RA Capital Management, LP
5.11%
Norges Bank Investment Management (NBIM)
3.42%
Frazier Life Sciences Management, L.P.
1.69%
ClearBridge Investments, LLC
1.61%
他の
81.97%
種類
株主統計
比率
Investment Advisor/Hedge Fund
11.71%
Investment Advisor
5.60%
Venture Capital
5.36%
Hedge Fund
4.22%
Sovereign Wealth Fund
3.42%
Individual Investor
1.91%
Private Equity
1.69%
Research Firm
1.50%
Pension Fund
0.05%
他の
64.54%
機関投資家保有株
更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q4
280
37.42M
42.38%
--
2026Q1
352
37.82M
33.67%
-10.78M
2025Q4
370
44.73M
39.84%
-12.84M
2025Q3
372
46.61M
41.70%
-15.37M
2025Q2
394
60.58M
54.15%
-11.96M
2025Q1
453
59.51M
53.68%
-14.18M
2024Q4
446
60.80M
55.47%
-4.29M
2024Q3
439
51.45M
51.99%
-10.14M
2024Q2
454
47.04M
47.66%
-14.67M
2024Q1
465
46.22M
46.47%
-13.77M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
RTW Investments L.P.
6.96M
6.14%
+4.67M
+203.71%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
3.84M
3.39%
+3.84M
--
Dec 31, 2025
Frazier Life Sciences Management, L.P.
1.90M
1.68%
+275.00K
+16.90%
Dec 31, 2025
ClearBridge Investments, LLC
1.81M
1.59%
-1.71M
-48.63%
Dec 31, 2025
Citadel Advisors LLC
1.69M
1.49%
+700.80K
+71.00%
Dec 31, 2025
Fidelity Management & Research Company LLC
1.44M
1.27%
-2.84M
-66.32%
Dec 31, 2025
Baron Capital Management, Inc.
1.42M
1.25%
+46.76K
+3.41%
Dec 31, 2025
Adar1 Capital Management LLC
1.25M
1.1%
+377.74K
+43.48%
Dec 31, 2025
Du (Ying Samantha)
1.06M
0.94%
+145.74K
+15.88%
Mar 11, 2026
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Tema Oncology ETF
1.67%
ALPS Medical Breakthroughs ETF
1.19%
Virtus LifeSci Biotech Products ETF
0.97%
Invesco Golden Dragon China ETF
0.58%
National Security Emerging Markets Index ETF
0.39%
iShares Biotechnology ETF
0.18%
Capital Group New Geography Equity ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.12%
ActivePassive International Equity ETF
0.03%
詳細を見る
Tema Oncology ETF
比率1.67%
ALPS Medical Breakthroughs ETF
比率1.19%
Virtus LifeSci Biotech Products ETF
比率0.97%
Invesco Golden Dragon China ETF
比率0.58%
National Security Emerging Markets Index ETF
比率0.39%
iShares Biotechnology ETF
比率0.18%
Capital Group New Geography Equity ETF
比率0.15%
ProShares Ultra Nasdaq Biotechnology
比率0.12%
Invesco Nasdaq Biotechnology ETF
比率0.12%
ActivePassive International Equity ETF
比率0.03%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
